Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Chidamide in the Maintenance Therapy of High-Risk Acute Myeloid Leukemia Patients: A Multi-center Real-World Study

NCT07822789 is registered in ClinicalTrials.gov with Guangdong Second Provincial General Hospital as lead sponsor.

NCT NCT07822789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07822789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Chidamide in the Maintenance Therapy of High-Risk Acute Myeloid Leukemia Patients: A Multi-center Real-World Study
Lead sponsor
Guangdong Second Provincial General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 27, 2026
Completion date
July 31, 2027
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, maintenance therapy